Gianluca D’Ippolito

Dr. Gianluca D’Ippolito


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Bone
Verified
Journal Article
Closed access
GDGianluca D’Ippolito
Gianluca D’Ippolito
SDSylma Diabira
Sylma Diabira
GHGuy A. Howard
Guy A. Howard
BRBernard A. Roos
Bernard A. Roos
PSPaul C. Schiller
Paul C. Schiller

1 August 2002 in Bone
Verified
Journal Article
Closed access
GDGianluca D’Ippolito
Gianluca D’Ippolito
PSP.C Schiller
P.C Schiller
CPC Perez-Stable
C Perez-Stable
WBW Balkan
W Balkan
BRB.A Roos
B.A Roos
GHG.A Howard
G.A Howard

1 February 2017 in Biomedical Materials
Verified
Journal Article
Closed access
PDF file
CGCristina Grau-Monge
Cristina Grau-Monge
GDGaëtan J-R Delcroix
Gaëtan J-R Delcroix
ABAndrea Bonnin-Marquez
Andrea Bonnin-Marquez
MVMike Valdes
Mike Valdes
EAEad Lewis Mazen Awadallah
Ead Lewis Mazen Awadallah
GDGianluca D’Ippolito
Gianluca D’Ippolito
Peripheral vascular disease is one of the major vascular complications in individuals suffering from diabetes and in the elderly that is associated with significant burden in terms of morbidity and mortality. Stem cell therapy is being tested as an attractive alternative to traditional surgery to prevent and treat this disorder. The goal of this study was to enhance the protective and reparative potential of marrow-isolated adult multilineage inducible (MIAMI) cells by incorporating them within a bio-inspired construct (BIC) made of two layers of gelatin B electrospun nanofibers. We hypothesized that the BIC would enhance MIAMI cell survival and engraftment, ultimately leading to a better functional recovery of the injured limb in our mouse model of critical limb ischemia compared to MIAMI cells used alone. Our study demonstrated that MIAMI cell-seeded BIC resulted in a wide range of positive outcomes with an almost full recovery of blood flow in the injured limb, thereby limiting the extent of ischemia and necrosis. Functional recovery was also the greatest when MIAMI cells were combined with BICs, compared to MIAMI cells alone or BICs in the absence of cells. Histology was performed 28 days after grafting the animals to explore the mechanisms at the source of these positive outcomes. We observed that our critical limb ischemia model induces an extensive loss of muscular fibers that are replaced by intermuscular adipose tissue (IMAT), together with a highly disorganized vascular structure. The use of MIAMI cells-seeded BIC prevented IMAT infiltration with some clear evidence of muscular fibers regeneration.

1 February 2009 in Current Rheumatology Reviews
Verified
Journal Article
Closed access
PDF file
PSPaul C. Schiller
Paul C. Schiller
GDGianluca D’Ippolito
Gianluca D’Ippolito
Injured cartilage tissue has a limited capacity to heal. There is increasing need for the development of biologically based approaches for cartilage repair. The ultimate aim is to repair the damaged cartilage tissue with new functional tissue using living cells (alone or in combination with suitable scaffolds) that will integrate with the patients remaining tissue and yield a regenerated functional joint, which could continue to repair itself and maintain tissue homeostasis, and remain functional throughout the life of the patient. Cell therapy approaches represent a novel strategy in the treatment of cartilage diseases. Among the different types of stem/progenitor cells that are currently being evaluated, the benefits and limitations of approaches using embryonic and adult stem cells will ultimately depend on factors related to efficacy and safety. To achieve these goals a clear and profound understanding of the molecular determinants of chondrocyte differentiation and cartilage tissue formation is essential, including the specific effect of trophic factors guiding the chondrogenic differentiation process, their relationship with the tissue microenvironment, and how they translate to an epigenetically stable and homogeneous functional tissue. Despite the increasing progress in the application of human embryonic stem cells for cartilage repair, ethical and safety concerns (primarily teratoma and tumor formation) remain to be resolved. Adult stem cells have demonstrated the greatest promise and bone marrow-derived stromal cell subpopulations represent the most widely studied cell types. Developmentally immature marrow stromal cells have been isolated by several groups which appear capable of meeting most, if not all, of the criteria needed for a successful approach. Here we will review the use of embryonic and adult stem cells for cartilage tissue engineering.